Research


Macroeconomic Modeling and Financial Stability: Lessons from the Crisis

Banking Perspective 2(2014), 22-31

View abstract

To Cure Cancer, Provide a Profit Motive

with Roger M. Stein, Scientific American Forum

View abstract

Dealing with Femtorisks in International Relations

with Aaron Benjamin Frank, Margaret Goud Collins, Simon A. Levin, Andrew W. Lo, Joshua Ramo, Ulf Dieckmann, Victor Kremenyukf, Arkady Kryazhimskiy, JoAnne Linnerooth-Bayer, Ben Ramalingam, J. Stapleton Roy, Donald G. Saari, Stefan Thurner, and Detlof von Winterfeldt, Proceedings of the National Academy of Sciences 111(2014), 17356–17362.

View abstract

Hedge Fund Beta Replication: A Five-Year Retrospective

with Peter A. Lee, Journal of Investment Management 12(2014), 5–18

View abstract

Financing Drug Discovery for Orphan Diseases

with David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein, Drug Discovery Today 19 (2014), 533-538

View abstract

Wall Street’s Next Bet: Cures for Rare Diseases

Fortune

View abstract

New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

with Sourya V. Naraharisetti, Journal of Investment Management

View abstract

Financial Orphan Therapies Looking For Adoption

with Vikas Sukhatme, Kathy Fang, Vidula Sukhatme, Health Affairs Blog

View abstract

Open-Source Software for “Financing Drug Discovery for Orphan Diseases”

with David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein

View abstract

Unintended Consequences of Expensive Cancer Therapeutics— The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

with Tito Fojo, Sham Mailankody, JAMA Otolaryngology-Head & Neck Surgery (2014)

View abstract

Follow me on © 2018 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design